KRISTIN MARTIN: Open Payments
NPI 1457520348 · SWANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,589 in 92 payments from 24 companies in 2025. Trend: 2023 $597 · 2024 $884 · 2025 $1,589
Food & beverage: $1,589
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $287 |
| Novo Nordisk Inc | 15 | $225 |
| Lilly USA, LLC | 12 | $218 |
| AstraZeneca Pharmaceuticals LP | 5 | $96 |
| Otsuka America Pharmaceutical, Inc. | 5 | $84 |
| Esperion Therapeutics, Inc. | 5 | $83 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $75 |
| Amgen Inc. | 4 | $69 |
| Aimmune Therapeutics, Inc. | 3 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
Products named: VRAYLAR, MOUNJARO, Ozempic, REXULTI, NEXLETOL, XIFAXAN, QULIPTA, Rybelsus.
Industry payments across OH — which companies pay providers there.
